EUVIMEDEUVIMED entdecken
Crossref

Has the Era of Individualized Intrauterine Treatment for Congenital Adrenal Hyperplasia Arrived?

Xinyu Fu iD, Yanjie Xia, Shaojun Li, Zhenhua Zhao, Lingrong Kong iD, Jingqi Zhu iD, Huanyun Li, Shitong Wu, Di Wu, Xiangdong Kong iD

Prenatal Diagnosis · 2025

DOI: 10.1002/pd.6747 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Prenatal Diagnosis, 2025. Verfasst von Xinyu Fu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Genetic and Prenatal Diagnosis Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Adrenal Hyperplasia, Congenital, Noninvasive Prenatal Testing, Fetal Therapies, Precision Medicine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Guangxi Key Laboratory of Reproductive Health and Birth Defect Prevention, Henan Province Medical Science and Technique Foundation, First Affiliated Hospital of Zhengzhou University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Congenital adrenal hyperplasia (CAH) is a common metabolic genetic disease. Early diagnosis and intervention are crucial to improve the prognosis. Noninvasive prenatal diagnosis (NIPD) is an early, safe, and accurate method. This study aimed to evaluate the NIPD of CAH while guiding individualized intrauterine treatment.

Methods

Twenty families with a 25% risk of having a baby with 21‐hydroxylase deficiency (21‐OHD) were included. Haplotypes were constructed based on targeted sequencing and family linkage analysis. Relative haplotype dosage (RHDO) combined with Bayes factor was used to infer fetal genotypes. Invasive prenatal diagnosis was performed to verify the reliability of NIPD. For affected‐female fetuses, intrauterine treatment was applied until delivery.

Results

In 20 families, NIPD successfully identified one female‐affected fetus, four male‐affected fetuses, nine heterozygotes, and five normal fetuses. The first‐pass success rate of NIPD was 90% (18/20), the reporting rate was 95% (19/20), and the accuracy was 100% (19/19). Individualized intrauterine treatment avoided 88.9% (8/9) of unnecessary treatment of unaffected female fetuses. Moreover, no significant virilization was observed in the newborn of CAH16, which underwent intrauterine treatment.

Conclusion

NIPD has far‐reaching implications for the early treatment and clinical management of pregnancy in families with 21‐OHD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenal Hyperplasia, CongenitalNoninvasive Prenatal TestingFetal TherapiesPrecision MedicineHumansFemalePregnancyMaleAdultInfant, NewbornHaplotypes

Stichwörter der Autor:innen

bayes factorcongenital adrenal hyperplasiaintrauterine treatmentnoninvasive prenatal diagnosisrelative haplotype dosage

Autor:innen und Institutionen

  • Genetic and Prenatal Diagnosis Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Research and Development Department, Celula (China) Medical Technology Co., Ltd., Chengdu, China.
  • Department of Fetal Medicine & Prenatal Diagnosis Center, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China.

ORCID-Profile: Xinyu Fu, Lingrong Kong, Jingqi Zhu, Xiangdong Kong

Förderung

  • Guangxi Key Laboratory of Reproductive Health and Birth Defect Prevention
  • Henan Province Medical Science and Technique Foundation
  • First Affiliated Hospital of Zhengzhou University

Zitieren

APA

Fu, X., Xia, Y., Li, S., Zhao, Z., Kong, L., Zhu, J., Li, H., Wu, S., Wu, D., & Kong, X. (2025). Has the Era of Individualized Intrauterine Treatment for Congenital Adrenal Hyperplasia Arrived?. Prenatal Diagnosis. https://doi.org/10.1002/pd.6747

Vancouver

Fu X, Xia Y, Li S, Zhao Z, Kong L, Zhu J, et al. Has the Era of Individualized Intrauterine Treatment for Congenital Adrenal Hyperplasia Arrived?. Prenatal Diagnosis. 2025. doi:10.1002/pd.6747

BibTeX
@article{Fu2025,
  author = {Fu, Xinyu and Xia, Yanjie and Li, Shaojun and Zhao, Zhenhua and Kong, Lingrong and Zhu, Jingqi and Li, Huanyun and Wu, Shitong and Wu, Di and Kong, Xiangdong},
  title = {Has the Era of Individualized Intrauterine Treatment for Congenital Adrenal Hyperplasia Arrived?},
  journal = {Prenatal Diagnosis},
  year = {2025},
  doi = {10.1002/pd.6747}
}
Kostenlos starten →